Intended for healthcare professionals

  1. Interpreting the...
  2. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?
Education And Debate

Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

BMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7292.989 (Published 21 April 2001) Cite this as: BMJ 2001;322:989

Related articles

See more

Cited by...

  • Balanced resuscitation and earlier mortality end points: bayesian post hoc analysis of the PROPPR trial
  • Evaluating reporting of patient-reported outcomes in randomized controlled trials regarding inflammatory bowel disease: a methodological study
  • Systematic review of interventions targeting sickness absence among pregnant women in healthcare settings and workplaces
  • Effects of internet-based cognitive behavioural therapy and physical exercise on sick leave and employment in primary care patients with depression: two subgroup analyses
  • Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading
  • QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion?
  • Ophthalmic statistics note 7: multiple hypothesis testing--to adjust or not to adjust
  • Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
  • Oseltamivir: the real world data
  • The STICH Trial (Surgical Treatment for Ischemic Heart Failure): Mode-of-Death Results
  • Vitamin D and tuberculosis
  • Is a Subgroup Claim Believable?: A User's Guide to Subgroup Analyses in the Surgical Literature
  • Interpreting composite outcomes in trials
  • Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
  • New Utility of an Old Marker: Serial {alpha}-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
  • Predicting who will benefit from an Expert Patients Programme self-management course
  • The CAPRIE-Like Subgroups of CHARISMA: A CAPRIEciously Biased Analysis of an unCHARISMAtic Truth
  • Cluster randomised controlled trial of the effectiveness of primary care mental health workers
  • Warfarin vs aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID.
  • Endpoints in asthma drug trials - what do they mean?
  • How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?
  • Evaluating guidelines across primary care-secondary care interface
Back to top